Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - Taylor & Francis
Background Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
[HTML][HTML] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - ncbi.nlm.nih.gov
Background Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review.
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - europepmc.org
Background Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
[引用][C] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - cir.nii.ac.jp
Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell
lung cancer (NSCLC): a systematic literature review | CiNii Research CiNii 国立情報学研究所 …
lung cancer (NSCLC): a systematic literature review | CiNii Research CiNii 国立情報学研究所 …
Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review.
G Wagner, HK Stollenwerk, I Klerings… - …, 2020 - europepmc.org
Background Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …
immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD …